This initiative provides a fantastic opportunity to learn directly from key voices across the MSCA community, including insights from a project coordinator, beneficiary, and third-country partner, all sharing valuable lessons and best practices. We are proud to announce that our Managing Director, Professor Mo Alavijeh ( Pharmidex , University of Hertfordshire ), will participate in the Round Table Discussion on “MSCA Staff Exchanges: Challenges and Opportunities”, including an interactive Q&A session. Mo will be attending in person at the Universitat d'Alacan t and is looking forward to engaging with attendees, building new connections, and exploring collaborative opportunities, particularly with those interested in working alongside a UK-based SME deeply committed to international research excellence. Monika Holik , Begoña Arano , Sotirios Kiokias , Rodrigo Gutierrez Dominguez , Xavier Eekhout Chicharro , Joaquin Silvestre , Izaskun Lacunza , Julio Marchamalo Amado , Mónika Holik

At Pharmidex , we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers. This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases. Through our cutting-edge preclinical services, including: PK/ADME studies CNS penetration & efficacy models in vivo/in vitro pharmacology bioanalytical and regulatory support  we contribute to the development of safer, more effective therapies for blood cancers. 🧬 We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments. ❤️ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure. 🔗 Learn more and support the cause: https://www.dkms.org.uk